Newsletter

Hydroxychloroquine-Azithromycin Treatment For COVID-19 May Pose a Risk for Ventricular Arrhythmia

FDA Approves Two Formulations of Bempedoic Acid for LDL-C Reduction/h2>

AHA Releases 2020 Heart Disease & Stroke Statistics Update

ADA Releases 2020 Standards of Medical Care in Diabetes

DAPA-HF Study Illustrates Safety and Efficacy of Dapagliflozin In Heart Failure

FDA Approves Dapagliflozin for Heart Failure in Type 2 Diabetes

FDA Expands Recall of Common Blood Pressure Drug

Type 2 Diabetes and Cardiac Remodeling

Study finds no link between SGLT-2 inhibitors and fracture risk in patients with type 2 diabetes

FDA Panel Leans Against Eliminating PAD Device Access

Weight Loss With Metformin Maintained at 15 Years

Harmful Medications Prescribed to Nearly 25% of Patients with HFrEF

REDUCE-IT Trial Presents Updated Findings

ACC & AHA will release comprehensive guidelines for primary CVD prevention at ACC conference

SCIENTIFIC SPOTLIGHT

Role of Real-World Data on Treatment of T2DM

NEWEST PROJECT

Prior Authorization for Access Resource Center

MOMENT WITH A MEMBER

Keith C. Ferdinand, MD, FACC, FAHA

BOSTON HIGHLIGHTS

Read Press Release

CLINICALLY CURRENT CME

Access Your Online Education

SCIENTIFIC SPOTLIGHT

Meta-Analysis Reports Aggressive LDL-C Lowering Reduces Cardiovascular Risk

EVENT ANNOUNCEMENTS

Small Group Workshops

POPULAR PODCAST

Joel Kahn, MD

CLINICAL CASE CHALLENGE

Test Your Knowledge

Faculty Forum

CMHC faculty member Stephen Devries, MD

Best Blog

Fasting Diets Reduce Risk Factors For CVD

Upcoming Projects

The Cardiometabolic Chronicle

Featured Article

The Reality of Women and Cardiometabolic Disease